Clinical Roundup Eating primes immune cells for future responses, UPMC study finds May 01, 2026Vol.52 No.17
Drugs & Targets ODAC recommends against approval of camizestrant NDA, gives a nod to sNDA for capivasertib May 01, 2026Vol.52 No.17By Jacquelyn Cobb
Drugs & Targets FDA grants priority review for Ziihera in first-line HER2+ GEA May 01, 2026Vol.52 No.17
Drugs & Targets FDA approval of IDE supplement to expand Alpha DaRT IMPACT Trial to patients with pancreatic cancer receiving gemcitabine with abraxane May 01, 2026Vol.52 No.17
Drugs & Targets Unfold AI’s prostate cancer mapping added to regional CMS Physician Fee Schedule May 01, 2026Vol.52 No.17
PodcastThe Directors The Directors: UPMC’s Byrd and Jefferson’s Chapman speak about avoiding catastrophism and using bridge funding to keep labs open“There’s a tightening of the belt, and when the belt gets tightened, it has downstream effects.” April 24, 2026Vol.52 No.16By Claire Marie Porter and Paul Goldberg
NCI At AACR, Letai announces prevention and screening project for southern Appalachia, describes a future without paylinesThere’s “clear evidence that funding is moving and the system is working.” April 24, 2026Vol.52 No.16By Sara Willa Ernst
Problem: Misinformation and stigma prevent uptake of HPV vaccines and screening. Solution: A comic book April 24, 2026Vol.52 No.16By Jacquelyn Cobb
